Cross-checking a DCF against multiples

A discounted cash flow — the method that values a business as the present-day worth of all the cash it will ever produce — has a seductive flaw. It hands you a single, precise-looking number: fair value, ₹2,400 crore, to the rupee. The precision feels like authority. But a DCF is a long chain of forecasts multiplied together, and a spreadsheet will faithfully compound your optimism into a confident total without ever once blushing.

So here is the discipline that separates a useful DCF from a self-flattering one. Take the answer your DCF produced and turn it back into a multiple. Divide the fair value by this year's profit and you get an implied multiple — the P/E, or EV/EBITDA, that your DCF is quietly asserting the business is worth. Then ask one plain question: is that a multiple a company like this could ever actually earn?

If your DCF on a steady 12%-growing manufacturer implies a P/E of 60, you have not discovered a hidden gem — you have discovered a broken assumption, because no mature 12% grower trades at 60 for long, and the market that prices thousands of such companies is unlikely to be wrong by triple. The implied multiple is a smoke alarm wired to your assumptions. This module is about listening to it.

A DCF and a multiple are not rivals; they are two witnesses to the same event, and they lie in different ways. A DCF builds value from the ground up — cash flow by cash flow, year by year — and its great weakness is that tiny changes in a growth rate or a discount rate, applied over a decade, swing the answer enormously. A multiple works from the outside in — it borrows the price the market pays comparable businesses — and its great weakness is that the "comparable" companies may be mispriced, mid-cycle, or not truly comparable at all.

Because the two methods fail for unrelated reasons, they make a superb pair of cross-checks. When a careful DCF and a sober multiple land near each other, you gain real confidence: two independent roads reached the same town. When they diverge sharply, you have not been handed a verdict — you have been handed a lead. Something is driving the gap: an aggressive growth assumption in the DCF, or a peer group the market is pricing for a boom that will not last. Either way, the disagreement is information, and chasing it down is where the actual understanding happens.

This is why professionals almost never quote a DCF alone. They triangulate. A rough answer confirmed by two different methods is worth far more than a precise answer that only its own spreadsheet believes. The goal is not to find the one true number — no such number exists — but to bracket a defensible range and to understand exactly which assumption you are betting on.

There are two cross-checks worth running on every DCF. Both are simple division.

Cross-check one: the implied P/E on the whole answer. Take the equity fair value your DCF produced and divide it by this year's (or next year's) net profit. That is the P/E the market would have to award for your DCF to be right. illustrative

Anchor Ltd is a steady manufacturer. Your DCF says equity is worth ₹1,200 crore. This year's net profit is ₹40 crore. Implied P/E = 1,200 ÷ 40 = 30. Now look at what the market actually pays similar businesses: peers trade at 22–28. Your DCF is a shade above the top of that band — defensible if you can point to Anchor growing faster or earning higher returns than its peers, a warning if you cannot. If instead the implied P/E had come out at 60, the alarm would be screaming, and you would go back to hunt the assumption that produced it.

Cross-check two: the exit multiple hidden in the terminal value. Most of a DCF's value usually sits in its terminal value — the lump that stands in for every year beyond the explicit forecast. That lump quietly assumes a multiple, whether you named one or not. Drag it into the open by dividing the terminal value by the final-year earnings measure to reveal its exit multiple.

Suppose your perpetuity assumes year-10 free cash flow of ₹100 crore, a terminal growth of 5%, and a discount rate of 11%:

Terminal value = 100 × (1.05) ÷ (0.11 − 0.05) = 105 ÷ 0.06 = ₹1,750 crore.

Is ₹1,750 crore sane? Divide it by year-10 EBITDA — say ₹150 crore. The implied exit EV/EBITDA is 1,750 ÷ 150 ≈ 11.7. That is a multiple a mature company could genuinely trade at, so the terminal value is reasonable. But had the same perpetuity implied an exit multiple of 25, you would know instantly that your terminal assumptions had smuggled in the belief that Anchor stays a red-hot growth stock forever — which competition rarely permits. A sane exit multiple is a faded multiple; assuming a mature business keeps a growth-stock rating into perpetuity is the commonest way a DCF fools its own author.

Watch a triangulation resolve a disagreement. illustrative

You value Anchor Ltd two ways. Your DCF says ₹1,200 crore. A peer-multiple approach — applying the sector's median 25× P/E to Anchor's ₹40 crore profit — says ₹1,000 crore. A 20% gap. The lazy move is to average them to ₹1,100 crore and move on. The useful move is to ask why they differ.

You look. The DCF's higher answer comes almost entirely from one place: it assumes Anchor's margins expand for the next five years, lifting profit faster than revenue. The peer multiple assumes no such thing — it prices Anchor as an average member of its group. So the entire ₹200 crore gap is a single bet: will Anchor's margins expand as the DCF assumes? That is now a question you can actually research — pricing power, cost programmes, competitive intensity — instead of a vague unease about which spreadsheet to trust.

Triangulation is a discipline, not a truth machine, and it has real limits.

It cannot make two wrong methods right. If your DCF is optimistic and the peer group is itself priced for a boom, the two can agree beautifully and both be too high. Agreement narrows your uncertainty; it does not guarantee you are correct. The peers are a mirror, and a mirror in a bubble reflects the bubble.

It cannot tell you the "true" value, because there is no single true value to find. Value is the discounted worth of future cash, and the future is unknown — so every method produces an estimate, and the honest output is a range, never a point. The cross-check tightens the range and exposes the load-bearing assumption; it does not collapse the range to a certainty.

And it cannot substitute for judging the business. A sane implied multiple confirms your assumptions are not absurd; it does not confirm they are right. A 12% grower can plausibly justify a P/E of 30 — and still be a poor investment if that 12% quietly slows to 6%. The multiples tell you whether your DCF is internally sane. Whether the future it assumes will actually arrive is a matter of reading the company, not the arithmetic.

The cross-check itself can be misused, and here is where.

1. Averaging instead of investigating. Two methods differ, so the reader splits the difference and calls it rigour. The average hides the very thing worth knowing — the assumption the two methods disagree about. A gap is a question, not a number to smooth away.

2. Never revealing the exit multiple. A perpetuity growth rate looks innocent, but it always implies a multiple. Authors who never divide the terminal value back into an exit multiple routinely bake a growth-stock rating into a mature business without noticing.

3. Trusting a peer group blindly. "The sector trades at 25×" is only useful if the sector is fairly priced, mid-cycle, and genuinely comparable. Anchoring your DCF check to a set of over-loved peers imports their optimism straight into your "sanity" test.

4. Crowning one method the winner. Deciding in advance that "the DCF is truth and multiples are shortcuts" (or the reverse) destroys the whole benefit. The methods are useful because they are independent; anointing one turns two witnesses back into one.

5. Reverse-engineering the inputs. The worst abuse: seeing an implausible implied multiple and then raising the terminal growth or margin until the multiple looks fine. That is not a cross-check; it is bending the evidence to fit the verdict. The market price is the multiple the world is actually paying — treat it as the honest external check on your private spreadsheet, not as a number to argue away.